Atlas Trials

Evaluation of 611 in Combination With Topical Corticosteroid in Participants With Moderate to Severe Atopic Dermatitis

Clinical trial NCT06554847 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06554847
Sponsor
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Dermatitis, AtopicEczema, Atopic
Start date
2024-09-23
Primary completion
2025-10-12
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.